A Comparative Efficacy and Safety Study of Compound Carraghenates Cream With Mayinglong Musk Hemorrhoid Ointment in the Treatment of Hemorrhoids

Last updated: June 1, 2026
Sponsor: Xian-Janssen Pharmaceutical Ltd.
Overall Status: Completed

Phase

4

Condition

Hemorrhoids

Treatment

Mayinglong Musk Hemorrhoid Ointment

Carraghenates Cream

Clinical Study ID

NCT01881282
CR002125
TITC-CHN-IIS-02
  • Ages 16-75
  • All Genders

Study Summary

The purpose of this study is to compare the therapeutic effect and safety of compound carraghenates cream with Mayinglong musk hemorrhoid (swollen veins in the lower part of the rectum or anus) ointment in the treatment of hemorrhoids, especially regarding the relief of pain.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Participants who agree to participate in the current study

  • Participants having painful hemorrhoids (swollen veins in the lower part of therectum or anus [external hemorrhoid, mixed hemorrhoid, etc.])

  • Participants who did not use other topical drugs to treat their hemorrhoids a daybefore the inclusion

  • Participants who do not use drugs other than the study drug and the control drug totreat their hemorrhoids during the study period

Exclusion

Exclusion Criteria:

  • Participants having other anorectal diseases , such as anal fistula , anal cleft ,perianal abscess , and anorectal occupied lesions etc

  • Participants having hypersensitive predisposition or hypersensitive to any ofcomponents of the study drugs

  • Female participants under pregnancy or during breastfeeding period

  • Participants who fail to accept the scheduled visits or are lost to the visits

  • Participants complicated by serious cardio cerebro vascular diseases, hepatic andrenal diseases, diseases of hemopoietic system or mental disorders

Study Design

Total Participants: 123
Treatment Group(s): 2
Primary Treatment: Mayinglong Musk Hemorrhoid Ointment
Phase: 4
Study Start date:
December 14, 2006
Estimated Completion Date:
February 09, 2008

Study Description

This is an open-label (all people know the identity of the intervention), randomized (study drug assigned by chance), multi-center (when more than one hospital or medical school team work on a medical research study), controlled clinical trial and comparative study of safety and efficacy of compound carraghenates cream with Mayinglong musk hemorrhoid ointment in the treatment of hemorrhoids, especially regarding the relief of pain. Participants will be randomly assigned to either of the two treatment groups that are carraghenates cream (Titanoreine) group or Mayinglong musk hemorrhoid ointment group. The total duration of the study will be 1 Week (7 days). In carraghenates cream group, 3-4 gram (g) cream will be administered each time through anal canal, twice a day, once in the morning and once in the evening for consecutive 6 days and in the Mayinglong musk hemorrhoid ointment group, 2 g ointment will be administered each time through anal canal, twice a day, once in the morning and once in the evening for consecutive 6 days. Efficacy will be assessed by using Numeric Rating Scale (NRS) and participants' safety will be monitored throughout the trial.

Connect with a study center

  • Beijing Hospital

    Beijing, 100730
    China

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.